Ergoteles’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,891
Closed -$694K 1449
2022
Q4
$694K Sell
2,891
-50,312
-95% -$11.3M 0.03% 586
2022
Q3
$9.78M Sell
53,203
-14,358
-21% -$2.86M 0.34% 46
2022
Q2
$11.4M Buy
+67,561
New +$14.5M 0.34% 75
2022
Q1
Sell
-104,346
Closed -$26.8M 1382
2021
Q4
$26.8M Sell
104,346
-11,426
-10% -$2.8M 1.04% 14
2021
Q3
$28.1M Buy
+115,772
New +$28.3M 1.03% 12
2021
Q1
Sell
-4,170
Closed -$686K 907
2020
Q4
$686K Sell
4,170
-230
-5% -$33.6K 0.02% 401
2020
Q3
$549K Buy
+4,400
New +$545K 0.07% 219

Other funds holding HCA

Ergoteles's HCA Position: Q1 2023 in Review

Ergoteles sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 2,891 shares — an estimated $694K sold.

Ergoteles first reported a position in HCA in Q3 2020 and held it in 7 quarters. The position peaked at $28.1M in Q3 2021. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Ergoteles reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 2,891 HCA Healthcare shares in Q1 2023, an estimated $694K.
  • Ergoteles first reported a position in HCA Healthcare in Q3 2020 and held it in 7 quarters.
  • Ergoteles's HCA Healthcare position peaked at $28.1M in Q3 2021.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.